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Abstract
More than 75% of emerging infectious diseases are zoonotic in origin and a transdisciplinary, multi-sectoral One
Health approach is a key strategy for their effective prevention and control. In 2004, US Centers for Disease Control
and Prevention office in Kenya (CDC Kenya) established the Global Disease Detection Division of which one core
component was to support, with other partners, the One Health approach to public health science. After catalytic
events such as the global expansion of highly pathogenic H5N1 and the 2006 East African multi-country outbreaks
of Rift Valley Fever, CDC Kenya supported key Kenya government institutions including the Ministry of Health and
the Ministry of Agriculture, Livestock, and Fisheries to establish a framework for multi-sectoral collaboration at
national and county level and a coordination office referred to as the Zoonotic Disease Unit (ZDU). The ZDU has
provided Kenya with an institutional framework to highlight the public health importance of endemic and
epidemic zoonoses including RVF, rabies, brucellosis, Middle East Respiratory Syndrome Coronavirus, anthrax and
other emerging issues such as anti-microbial resistance through capacity building programs, surveillance, workforce
development, research, coordinated investigation and outbreak response. This has led to improved outbreak
response, and generated data (including discovery of new pathogens) that has informed disease control programs
to reduce burden of and enhance preparedness for endemic and epidemic zoonotic diseases, thereby enhancing
global health security. Since 2014, the Global Health Security Agenda implemented through CDC Kenya and other
partners in the country has provided additional impetus to maintain this effort and Kenya’s achievement now
serves as a model for other countries in the region.
Significant gaps remain in implementation of the One Health approach at subnational administrative levels; there
are sustainability concerns, competing priorities and funding deficiencies.
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Background
More than 75% of emerging and re-emerging infectious
diseases are of zoonotic origin including Severe Acute
Respiratory Syndrome (SARS), highly pathogenic avian
influenza (HPAI), Middle East Respiratory Syndrome
(MERS), and Rift Valley Fever (RVF). These can cause
explosive global outbreaks resulting in substantial eco-
nomic and public health burden [1]. Moreover, zoonotic
pathogens may spill over to human hosts and in some
cases result in a considerable endemic health burden.
This is especially true in low resourced and rural set-
tings, where livestock play a central role in daily life and
people interact closely with their animals through shared
housing and during routine husbandry practices includ-
ing herding, milking, helping with birthing process and
deworming. In addition, various cultural norms in some
communities promote consumption of unprocessed live-
stock products such as unpasteurized milk and unin-
spected meat. As a result, this expanded and close
human-animal interface in countries such as Kenya
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presents a threat for increased transmission of zoonotic
pathogens between animals and humans along the live-
stock value chain, increasing the likelihood of novel zoo-
notic pathogens establishing themselves in human
populations, the overall endemic burden of common
zoonoses, and the threat of infectious disease outbreaks
which can threaten global health security.
One Health approach has been defined by the Ameri-
can Veterinary Medical Association as the integrative ef-
fort of multiple disciplines working locally, nationally,
and globally to attain optimal health for people, animals,
and the environment [2]. Globally, the recognition of the
threat of emerging and re-emerging zoonoses led to ad-
vocacy for the adoption of a One Health approach at
country level aimed at strengthening monitoring and re-
sponse to zoonotic disease risks via a multisectoral,
transdisciplinary collaboration [3, 4]. In practice, differ-
ent countries have approached implementation the
principle of One Health variously with varying successes
and challenges [5]. In Kenya, creation of a coordination
framework between public health and animal (domestic
and wildlife) health sector to understand, prevent and
control re-emerging and endemic zoonotic diseases has
played a central role in the adoption and implementa-
tion of the One Health approach.
In Kenya, livestock contributes over 5.5% of the Na-
tional Gross Domestic Product [6]. About 60% of all cat-
tle, sheep and goats is found in arid and semi-arid areas,
where approximately 10 million Kenyans derive their live-
lihood from livestock. Even in non-arid and semi-arid
rural regions of Kenya, most farmers practice mixed farm-
ing that includes livestock ownership. For example, among
1500 households participating in a study in Western
Kenya, within a non-arid and semi-arid area, 93% of
households owned at least one type of livestock with 88%
keeping chickens, 55% keeping cattle, 41% keeping goats,
and 19% keeping sheep [7].
In 2004, the US CDC, in collaboration with the Kenya
Medical Research Institute (KEMRI) and the Kenya
Ministry of Health, established the Global Disease De-
tection Division (GDDD) at CDC Kenya to facilitate
building diagnostic and epidemiologic capacity for epi-
demic prone diseases, conducting public health research
of global importance, and contributing to development
and use of effective interventions to reduce impact of
diseases. Within the GDDD, zoonotic diseases research
and a One Health approach were identified as key focus
areas with dedicated funding and personnel to lead this
effort within the One Health Program formally set up in
2010. The GDDD’s One Health program focused on en-
hancing collaboration between human and animal health
sectors, improving surveillance and diagnostic capacity
for the animal health sector and conducting research at
the human-animal interface.
Here, we highlight the successes and challenges of the
GDDD (now called the Division of Global Health Protec-
tion – DGHP) in the last decade, specifically in 1) develop-
ing institutional capacity for One Health implementation,
2) strengthening capacity for surveillance and reporting in
animal health sector and 3) expanding the research capacity
in Kenya and the East Africa region. In addition, we high-
light implementation challenges and recommendations to
achieve the full benefits of the One Health approach.
One health institutional capacity
A framework for collaboration
Kenya adopted the One Health approach in 2006 by es-
tablishing a multi-sectoral committee aligned with global
recommendation to coordinate preparedness efforts to
prevent the spread HPAI in the wake of the global
spread of H5N1. This framework was quickly tested by
an outbreak of RVF in the Eastern Africa Region during
2006–2007. Previously, despite the endemicity of RVF
and the relative predictability of epidemics, the 1996–
1997 RVF outbreak in Kenya caught public health au-
thorities unprepared. Delays in detection and response
combined with the lack of local capacity for diagnostic
testing (specimens were tested late in the outbreak’s
course at the National Institute of Communicable Dis-
eases in South Africa) likely contributed to the large
1996/7 outbreak resulting in 27,500 human infections
and 170 deaths in Garissa in North Eastern Kenya. The
outbreak was associated with large, but mostly undocu-
mented socio-economic impacts resulting from animal
deaths [8, 9]. In contrast, the 2006/07 RVF outbreak in
Kenya that was more geographically widespread was
characterized by a more timely diagnosis and better co-
ordinated response and resulted in 700 suspected human
cases and 90 deaths. This enhanced response could in
part be credited to the efforts to build capacity for coor-
dinated outbreak response and communication pathways
within the Ministry of Health (MoH) and Ministry of
Agriculture, Livestock, and Fisheries (MALF), through
increased human capacity, the presence of a multisec-
toral coordination structure arising from the HPAI pre-
paredness effort and enhanced diagnostic capacity in
local government, and improved research infrastructure
including a BSL-3 laboratory at KEMRI supported by
CDC Kenya [10–12]. The 2006/07 RVF outbreak played
a key role in galvanizing collaboration in One Health ap-
proaches among government departments, researchers
and international organizations to mitigate impacts of
future outbreaks and catalyzed the need for clearer un-
derstanding and adoption of One Health approach with
a focus on supporting animal health surveillance activ-
ities [10]. This success with RVF, demonstrated the need
to expand and improve the approach for all potentially
zoonotic outbreaks, but also to understand, prevent and
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control endemic zoonotic disease. In Particular a lack of
a formal framework for systematic collaboration be-
tween government Ministries and among key stake-
holders on management of zoonotic disease outbreaks
was a critical gap.
DGHP’s One Health Program worked with other part-
ners including the US Cooperative Biological Engage-
ment Program of the Department of Defense and
Biological Engagement Program of the Department of
State, to continually advocate for and provide technical
and financial assistance to the establishment of a formal
collaborative framework between the public and animal
health sectors. These efforts led to the formation of a
national One Health coordinating office referred to as
Zoonotic Disease Unit (ZDU) in 2012 and the process to
do this has been laid out previously [13] (Fig. 1).
The ZDU’s key mandate was to act as a focal point of
collaboration between the MoH and the MALF with a
goal to establish structures and partnerships that pro-
mote the One Health approach, to enhance or build zoo-
notic epidemic and endemic disease surveillance, and to
coordinate implementation of control measure and to
support public health research in Kenya [13, 14].
In 2013, the governance system in Kenya changed
from a centralized to a devolved government of 47 coun-
ties; where functions such as public health and animal
were undertaken by county governments. This provided
an opportunity and need to expand the One Health ap-
proach to the subnational (county) level. To cascade the
benefits of One Health approach to the county level, the
ZDU and its partners have embarked in training and
setting up county One Health units supported mainly
through CDC Kenya’s Global Health Security Agenda
(GHSA) implementing partners. County One Health
units focus on initiating or enhancing communication
platforms between the health and livestock sectors to
improve surveillance and reporting of zoonotic diseases,
ensuring rapid joint investigation and response to zoo-
notic disease outbreaks to mitigate disease impact. As of
April 2017, there were 31 of 47 Kenya counties with
established county One Health units. Through collabo-
rations with other international partners, there will be
county One Health units in all 47 counties by 2019.
Sharing of disease outbreak information across sectors
and rapid joint outbreak response at county level
should help reduce the burden of spillover to humans
that acquire zoonotic disease infections as illustrated by
an example of an anthrax outbreak in Nakuru County
(Table 1).
In 2015, a multidisciplinary team of human, animal
and wildlife health experts in surveillance, research and
laboratory science drawn from the national and county
levels conducted prioritization of zoonotic diseases in
Kenya [15]. From a list of 35 zoonotic diseases, the top
five were anthrax, trypanosomiasis, rabies, brucellosis
and Rift Valley Fever. Based on these findings, develop-
ment and implementation of disease prevention and
control plans for these priority zoonoses with greatest
public health impact is being undertaken while promot-
ing collaborative research and surveillance for all the
diseases to generate national data and for evaluating
control strategies.
Fig. 1 Major milestones on One Health implementation and publications on zoonoses by year, CDC-Kenya, 2004–2017. Global Disease Detection
Division (GDDD) now called the Division of Global Health Protection (DGHP); Field Epidemiology and Laboratory Training program (FELTP);
Ministry of Health (MOH)
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One Health workforce development
In 2004, the Kenya Ministry of Health, with support
from CDC and other partners, launched Kenya’s Field
Epidemiology and Laboratory Training Program
(FELTP). This program provides training in applied
epidemiology, resulting in a Master’s of Science
(MSc), initially offered to medical doctors and labora-
tory scientists working within government ministries
[16]. Since 2006, with increased recognition of the
value of One Health, veterinarians have been admitted
to the training [16]. By 2017, the Kenya FELTP had
169 medical and 19 veterinary epidemiologists
complete the two-year training program. Of these
trained veterinarians, all initially returned to govern-
ment positions, and the majority stayed at national or
country level, strengthening collaboration between the
human and animal health sector with fellow FELTP
graduates participating in joint outbreak response and
other activities during their training (Fig. 2).
Surveillance
Surveillance for animal diseases in most developing
countries is designed to detect notifiable and trade
sensitive diseases (e.g. foot and mouth disease) and to
report to the World Organization for Animal Health
(OIE). However, these systems are established to de-
tect animal syndromes and generally without consid-
eration of zoonotic aspects of clusters of animal
diseases and the risk that infections may spill-over to
humans locally and further afield. This calls for estab-
lishment of surveillance platforms that can detect and
report cases of these zoonotic diseases in a timely
manner, coupled with enhanced collaboration and in-
formation sharing between human health and animal
health sectors.
In September 2015, the United States’ Pandemic and
Forecasting Science Technical Working Group and the
Food and Agriculture Organization issued an alert pre-
dicting a high likelihood of El Niño-type rainfall and
subsequent potential for an RVF epidemic in the Eastern
Africa region, and covering the known high risk areas of
RVF in Kenya [17, 18]. In response to the alert, CDC
Kenya, in collaboration with Kenya MALF (through
GHSA funding), set up a mobile phone-based enhanced
active surveillance system between November 2015 and
February 2016 in 22 (of 47) RVF high-risk counties. The
surveillance system collected environmental and live-
stock monitoring data from resident veterinary officers
at county and sub-county level on weekly basis and pro-
vided for toll free telephone contact to headquarters in
order to report any suspected RVF cases. The veterinary
surveillance officers contacted a network of farmers
spread out through the sub counties. Over 10,000 re-
ports were submitted with 66 of the syndromic reports
meeting the suspect case definition for RVF [19], how-
ever none was confirmed, and the conclusion was that
no RVF in livestock had actually occurred. Although an
outbreak had not occurred, the potential of one provided
an opportunity to test a coordinated, rapid and en-
hanced surveillance response, highlighting possibility of
a more robust and real-time reporting tool in place of a
variety of manual and electronic tools that have been
used with varied success.
In Kenya, the current surveillance effort is focusing
on development and deployment of syndromic sur-
veillance system in domestic and wild animals, using
a mobile phone based application that will incorpor-
ate reporting and a feedback function to the surveil-
lance officers and has capabilities for routine data
analysis and visualization to detect animal disease
events of public health concern. The mobile applica-
tion has adapted manual disease reporting forms
currently in use for reporting. Nine syndromes are
targeted for reporting: abortion, sudden death,
hemorrhagic, neurologic, respiratory, animal bites and
oral/foot lesions. Since this mobile phone based appli-
cation can be downloaded onto any android-based
mobile phone device, this reporting tool promises to
greatly enhance real-time surveillance within Kenya’s
animal health sector. This surveillance is part of insti-
tutional capacity building funded by GHSA and
targeted to reach up to 10 counties by 2019.
Table 1 Description of an outbreak of anthrax in humans and
livestock in Nakuru County, 2016
Anthrax is endemic in Nakuru County, where outbreaks in animals are
reported annually. In June 2016, a farmer from one village sent samples
from his animal that had died suddenly to the Nakuru Regional
Veterinary Investigations Laboratory. These samples tested positive for
anthrax. Officers at the regional laboratory notified officers at the sub-
county veterinary department, who in turn immediately notified the
sub-county department of health in Nakuru County. The sub-county offi-
cers of health visited the village to trace the affected farmers’ household,
sensitize the community, and health workers and offered prophylaxis
treatment to those who had been exposed (eaten meat from the ani-
mals or slaughtered/skinned) to dead animals. The veterinary depart-
ment carried out anthrax ring vaccination of livestock as an outbreak
control measure. Upon further records review at the veterinary depart-
ment, the team identified that a total of 10 cows had died between
May and June 2016 of suspected anthrax infection.
In July 2016, ZDU and Kenya Field Epidemiology and Laboratory
Training Program (FELTP) conducted an outbreak investigation at local
health centers. A total of 73 exposed people on the investigators’
outbreak line-list were classified as probable cases; 29 of them were
traced and 3 (10%) had developed cutaneous anthrax. The majority of
those who did not develop clinical disease reported having received
prophylaxis treatment at the local health center offered as public health
response to the confirmed animal case. The three cutaneous anthrax
cases were all exposed from the same animal carcass and all resided in
the same village. The timely communication between the health sectors
and intervention in those exposed resulted in fewer human cases during
this outbreak. The rapid detection and control of this outbreak at its
source illustrates the importance of the One Health approach for global
health security.
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Zoonotic disease research in Kenya
The burden and transmission dynamics of many zoo-
notic infections are poorly understood in developing
countries, including Kenya, which can challenge the
progress of disease control programs to reduce burden
and impact. In 2005, KEMRI and the DGHP in Kenya
established the Population Based Infectious Disease
Surveillance (PBIDS) platforms in a rural site in West-
ern Kenya and an urban site in Nairobi to define the
burden, etiologies and risk factors of common infec-
tious disease syndromes (fever, jaundice, diarrhea and
respiratory illness) among others [20, 21]. Additionally,
in 2008 through collaborative partnerships with the
Wellcome Trust, zoonotic disease research was started
among farmers and animals within PBIDS. The zoo-
notic disease research in DGHP has catalyzed add-
itional studies within the PBIDS platform with other
partners such as Washington State University and de-
veloped further platforms in different sites in the coun-
try with the overall focus of generating disease data to
inform public health actions (Fig. 1). Some examples of
these are outlined below.
Q-fever
Coxiella burnetti is on the US Federal Select Agent list
and was first reported in Kenya over half a century ago,
but since the late 1970’s there had been no further study
of this pathogen. In 2009, KEMRI and CDC Kenya car-
ried out retrospective studies on archived human sera
collected between 2007 and 2008 in the PBIDS platform
and cross-sectional studies carried out in the same site
in 2009 among cattle, sheep and goats and the vector
ticks to determine the sero-prevalence of the disease
[22]. These pivotal studies by CDC and KEMRI triggered
a sustained interest among research groups who showed
variable but high sero-prevalence in humans and the res-
ervoir domestic animals in different eco-systems in
Kenya and highlighted Coxiella burnetti as a key etiology
for consideration for undifferentiated fever in communi-
ties keeping livestock [23, 24]. In 2015, data from these
studies were used during a One Health Zoonotic Disease
Prioritization workshop in Kenya, where Q-fever was
identified as one of the diseases that would benefit from
integrated prevention and control programs using the
One Health approach [15].
Fig. 2 Map of Kenya showing trained County One Health Units, Veterinary Field Epidemiology and Laboratory Training Program (FELTP)
graduates and research sites by county. County One Health Units (COHUs)
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Brucellosis
CDC Kenya and the ZDU implemented a study in three
counties among humans and their livestock and found a
varying (2.4–46.4%) seroprevalence in humans and 1.2–
13.5% in livestock among the counties, largely associated
with cultural practices around livestock and their products
particularly unpasteurized milk and low knowledge levels
on brucellosis. This underscored the need for targeted
public health messaging, effective diagnostic capacity in
local hospitals and systematic control programs for bru-
cellosis in animals [25].
Rift Valley fever
The momentum built around the 2006–2007 RVF out-
break in Kenya progressed to robust research projects by
multisectoral collaborative research groups. A key out-
put from learning the lessons on preparedness from the
2006–2007 outbreak is the RVF decision support tool kit
for Chief Veterinary officers in the Horn of Africa region
to support evidence-based actions to mitigate the impact
of RVF outbreaks when they occur [26]. This tool has
been adapted into the RVF integrated preparedness and
response plan for Kenya and was applied in late 2015
when RVF was predicted in Kenya and the Eastern Af-
rica region as described previously.
Other DGHP- Kenya research work on RVF described
climatic, geographic, and geologic predictive factors asso-
ciated with occurrence of RVF in Kenya [27, 28]. These
data taken together with a historical review of RVF out-
breaks since 1912, were used to generate a risk map for
RVF in Kenya [27, 29, 30]. A temporal spatial mapping of
the RVF outbreaks in the Eastern Africa region followed
by molecular analysis of viruses isolated from humans, an-
imals and mosquitoes found foci-specific viral lineages
suggesting de novo activation of viruses in specific out-
break sites rather than spatial spread from the initial out-
break site to another [31]. This knowledge was useful in
defining the endemic nature of RVF in certain regions in
Kenya and subsequent studies on factors associated with
endemicity, outbreak flare-ups and factors associated with
human morbidity and mortality [27, 32]. To address safety
concerns surrounding the locally available RVF vaccine, a
field trial to evaluate the safety and efficacy of new RVF
clone 13 vaccine was conducted in Kenya in collaboration
with Kenya Ministry of Agriculture Livestock and Fisher-
ies [33–35]. The results showed the vaccine as a promis-
ing tool, being safe and with high immunogenicity in
sheep and goats and moderate immunogenicity in cattle
under field conditions. This vaccine has been earmarked
for registration locally.
Rickettsia
Between 2006 and 2008 a hospital based study con-
ducted by KEMRI and CDC Kenya in North Eastern
Kenya identified for the first time, Rickettsia felis—an
agent of flea-borne spotted fever in 3.7% of patients [36].
A second study (2007–2010) in the PBIDS Lwak health
facility in Western Kenya reported 57% seroprevalence
of antibodies versus Rickettsial species in archived hu-
man sera. Rickettsia were detected by PCR in 7.2% of fe-
brile patients, which was 2-fold higher than in the
afebrile patients suggesting that Rickettsial pathogens
are an important differential diagnosis among patients
with undifferentiated fever in this region [37]. Subsequently
cross-sectional studies in PBIDS platforms found previous
exposure to spotted fever group rickettsia in goats (43%),
sheep (23%) and cattle (1%) and in majority (> 90%) of
Amblyomma variegatum tick pools and in 66% of flea pools
[38]. Further these studies identified, isolated and se-
quenced a novel (to the world) rickettsial pathogen, Rickett-
sia asemboensis in cat and dog fleas in western Kenya.
Middle East respiratory syndrome coronavirus
High seroprevalence of Middle East Respiratory Syn-
drome Corona Virus (MERS COV) among camels has
been reported in Kenya and other countries in Africa
[39, 40]. Kenya has over three million camels reared in
the arid northern part of the country. CDC Kenya in
collaboration with KEMRI assessed whether persons ex-
posed to seropositive camels (90% sero-prevalence) at
household level had serological evidence of infection.
None of the 760 persons tested with well-characterized
exposure to camels and camel products (milk) showed
evidence of previous exposure MERS COV [41]. To test
the hypothesis that perhaps a different strain of MERS
COV that is less transmissible from camels to humans is
circulating in camels in Kenya we have set up a study to
detect and isolate MERS virus strain circulating in
camels in Kenya for comparison with strains circulating
elsewhere and addition expanded an enhanced surveil-
lance of respiratory illness to Marsabit where camel pas-
toralists reside to detect any cases in humans.
Potential zoonotic pathogens in small mammals
In 2008, KEMRI and CDC conducted a study in the
urban (Nairobi) Kibera PBIDS platform with rodents
captured in and around houses and reported a diversity
of pathogenic leptospires [42]. Two studies carried out
by KEMRI and CDC on Bartonella in rodents and bats
captured in or around homesteads in Kibera PBIDS plat-
form found Bartonella strains that are closely related to
known human Bartonella species [43]. In addition, from
a variety of bats captured in multiple sites across Kenya,
a high prevalence and diversity of Bartonella species
were identified [44]. Detection of these pathogens in
these animal reservoirs suggests potential for exposure
and transmission to humans in different settings. Future
work is underway to understand the contribution of
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these pathogens as etiologies for undifferentiated fever
in humans using multi-pathogen detection assay such as
the AFI TaqMan array card in several sites including the
PBIDs platform in Western Kenya.
Linking animal ownership and health status to human
health outcomes
Since 2013, CDC and KEMRI in collaboration with
Washington State University have conducted animal
(cattle, sheep, goats, and poultry) syndromic surveillance
in 1500 households in Western Kenya, a subset of the
on-going PBIDS platform [7]. This integrated and unique
study design allows for measuring of the impact of live-
stock diseases on human health and socio-economic sta-
tus at household level. Preliminary data analysis reported
at household level, showed strong association between cu-
mulative human and animal illness though the mechanism
for this association was not clear [7]. Further work looking
at the linkage of human health and owning livestock
through the nutritional pathway as well as assessing the
level of microbiome development among children at
household level has yielded insights into the impact of ani-
mal ownership and animal source foods on growth and
development of children under 5 years old as well as the
factors associated with level of microbiome sharing [45,
46]. There are on-going studies on impact of interventions
to reduce diseases in animals on health and
socio-economic status of households.
In summary, the CDC, KEMRI and collaborators in-
vestments in research on zoonotic diseases has gener-
ated credible and useful data on occurrence, identified
new pathogens and etiologies of common syndromes,
clarified the ecology of disease occurrence and overall
contributed in the formulation of science-based inter-
ventions in endemic zoonotic diseases. In addition, the
innovative and unique linked human-animal interface
study designs have highlighted the benefits of adopting a
One Health approach in research to study zoonoses and
complex interlinked human and animal health relation-
ships. Overall, 30 publications covering viral, bacterial
and other (mainly reviews and topics on disease ecology)
have been realized from this work (Fig. 1).
Challenges
While zoonotic diseases spill-over to human populations
and the concept of controlling infections at source is
well appreciated, the animal health sector continues to
be under-resourced in critical elements of surveillance
and reporting of animal diseases and laboratory diagno-
sis. In addition, setting up surveillance programs is re-
source intensive with few partners providing support.
Convincing policy makers of the benefit of planning and
investing in animal surveillance for public health gain is
often challenged where data on burden of zoonoses are
scanty and when the threat is not immediately apparent
zoonotic and/or not an existing emerging disease threat.
On a positive note, in 2013 DGHP Kenya funded the de-
velopment of a rabies elimination plan for Kenya [14]
that has since attracted funding from various MALF and
MOH development partners for rabies elimination activ-
ities including mass dog vaccination, enhanced rabies sur-
veillance in humans and animals, enhanced management
of dog bite cases and operational research. Finally, the
Kenya ZDU has not fully incorporated the environment
health sector to be fully compliant with the scope of One
Health approach. This has in part been due to lack of
clearly designated government ministry that represents the
environment sector. Currently efforts have been made to
include an ecologist as a core personnel to the ZDU to pro-
vide environmental health expertise. In addition, the stra-
tegic plan for the implementation of One Health is being
reviewed to reflect the progress made and identify strategies
for institutionalizing One Health at sub-national level.
The change of Kenya’s governance structure from a
central to a devolved system in 2012 necessitated a dif-
ferent approach in the implementation of One Health.
The extent of adoption of the One Health approach has
been remarkable at the national level. However, at the
sub-national (County and sub-county levels) where most
disease management decisions are made, more progress
is needed. With GHSA support, the ZDU has made con-
certed efforts to establish functional One Health units at
county levels to enhance coordination and communica-
tion of key ministries and stakeholders for surveillance
and disease outbreak response; however the benefits of
these efforts are currently being evaluated. Finally, sus-
tainability of the current progress and efforts are not
guaranteed due to the reliance on donor funding to im-
plement these One Health activities. This is a challenge
that goes beyond One Health implementation and is
largely appreciated for many donor-initiated efforts.
Most governments have a host of competing interests in-
cluding constant outbreaks of epidemic prone diseases such
as cholera, other infectious diseases and non-communicable
diseases within the health sector and focusing on promotion
of international trade in animals and animal products that
often make the importance of zoonotic diseases pale in
comparison. Commendably, ZDU has initiated advocacy
plans to lobby for government support through the line
ministries to maintain One Health activities beyond the
current GHSA initiative.
Conclusions
Since 2006, CDC Kenya has successfully supported and
collaborated with Kenyan government institutions to es-
tablish a sustainable One Health program at national
and county levels; a process catalyzed by emerging zoo-
notic threats such as RVF and H5N1. The results have
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been the establishment of an effective cross-sectoral co-
ordinating government unit (ZDU), an enhanced surveil-
lance system in domestic and wild animals that meets
the needs of animal and human health, a workforce
trained in the One Health approach, improved outbreak
investigations and a robust and productive public health
scientific program including the discovery of zoonotic
pathogens new to the world. The adoption of the One
Health program and approach in Kenya has led to rapid
detection and control of zoonotic disease outbreaks at
their source and thereby enhanced global health security.
These achievements have allowed for advocacy and in-
formed decisions to be made on the control and preven-
tion of zoonotic pathogens and have identified gaps in
diagnosis and surveillance. However, challenges remain
in sustainability, veterinary laboratory diagnosis and re-
sources to implement more comprehensive control and
prevention measures.
Since zoonotic infections continue to impose a health
burden on population, and new zoonoses can emerge in
any country and spread globally, the regional and global
adoption of the One Health agenda is a key capacity of
the global health security agenda. Lessons learnt from
Counties in Kenya are applicable to establish One Health
programs throughout Kenya, the African region, and
beyond.
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